EDGAR Filing Documents for 0001140361-20-002839

Form 8-K - Current report:

SEC Accession No. 0001140361-20-002839

Filing Date

2020-02-11

Accepted

2020-02-11 17:26:53

Documents

Period of Report

2020-02-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	form8k.htm	8-K	25023
2	EXHIBIT 10.1	ex10_1.htm	EX-10.1	164602
3	EXHIBIT 99.1	ex99_1.htm	EX-99.1	13939
4		image00001.jpg	GRAPHIC	4478
	Complete submission text file	0001140361-20-002839.txt		211191

Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118

Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100

ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)